Development of Aflatoxin B1-Lysine Adduct Monoclonal Antibody for Human Exposure Studies

Applied and Environmental Microbiology

Volumn 67, Issue 6, 2001, Pages 2712-2717

  Wang, Jia Sheng ^a   Abubaker, Salahaddin ^b   He, Xia ^b   Sun, Guiju ^b   Strickland, Paul T ^b   Groopman, John D ^b  

^a Texas Tech University System   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; ANTIGEN; BOVINE SERUM ALBUMIN; CARCINOGEN; DRUG DERIVATIVE; LYSINE; MONOCLONAL ANTIBODY;

ARTICLE; BINDING COMPETITION; BLOOD; ENVIRONMENTAL EXPOSURE; HUMAN; IMMUNOLOGY; METHODOLOGY; RADIOIMMUNOASSAY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

AFLATOXIN B1; ANTIBODIES, MONOCLONAL; ANTIGENS; BINDING, COMPETITIVE; CARCINOGENS, ENVIRONMENTAL; ENVIRONMENTAL EXPOSURE; HUMANS; LYSINE; RADIOIMMUNOASSAY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SERUM ALBUMIN, BOVINE;

EID: 0035379709     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/AEM.67.6.2712-2717.2001     Document Type: Article

References (35)

1. Adam, W., Y.-Y. Chan, D. Cremer, J. Gauss, D. Scheutzow, and M. Schindler. 1987. Spectral and chemical properties of dimethyldioxirane as determined by experiment and ab initio calculations. J. Org. Chem. 52:2800-2803.
2. Baertschi, S. W., K. D. Raney, M. P. Stone, and T. M. Harris. 1988. Preparation of the 8,9-epoxide of the mycotoxin aflatoxin B1: the ultimate carcinogenic species. J. Am. Chem. Soc. 110:7929-7931.
3. Bauminger, S., and M. Wilchek. 1980. The use of carbodiimides in the preparation of immunizing conjugates. Methods Enzymol. 70:151-159.
4. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
5. Chapot, B., and C. P. Wild. 1991. ELISA for quantification of aflatoxin-albumin adducts and their application to human exposure assessment, p. 139-155. In M. Van Warhol, D. Velzen, and G. R. Bullock (ed.), Techniques in diagnostic pathology, vol. 2. Academic Press, Inc., New York, N.Y.
6. Eaton, D. L., and J. D. Groopman. 1994. The toxicology of aflatoxin: human health, veterinary and agricultural significance. Academic Press, San Diego, Calif.
7. Galfre, G., and C. Milstein. 1981. Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol. 73:1-46.
8. 1. Carcinogenesis 9:1323-1325.
9. Gange, S. J., A. Munoz, J.-S. Wang, and J. D. Groopman. 1996. Variability of molecular biomarker measurements from nonlinear calibration curves. Cancer Epidemiol. Biomark. Prev. 5:57-61.
10. 1-adducted DNA. Proc. Natl. Acad. Sci. USA 78:5445-5449.
11. Groopman, J. D., L. J. Trudel, P. R. Donahue, A. Rothstein, and G. N. Wogan. 1984. High affinity monoclonal antibodies for aflatoxins and their application to solid phase immunoassay. Proc. Natl. Acad. Sci. USA 81: 7728-7731.
12. Groopman, J. D., C. P. Wild, J. Hasler, C. Junshi, G. N. Wogan, and T. W. Kensler. 1993. Molecular epidemiology of aflatoxin exposure: validation of aflatoxin-N7-guanine levels in urine as a biomarker in experimental rat models and humans. Environ. Health Perspect. 99:107-113.
13. Groopman, J. D., G. N. Wogan, B. D. Roebuck, and T. W. Kensler. 1994. Molecular biomarkers for aflatoxins and their applications to human cancer prevention. Cancer Res. 54:1907s-1911s.
14. Harlow, E., and D. Lane. 1988. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
15. Harris, C. C., and T.-T. Sun. 1986. Interactive effects of carcinogens and hepatitis B virus in the pathogenesis of hepatocellular carcinoma. Cancer Surv. 5:765-780.
16. Hill, P. G., and T. N. C. Wells. 1983. Bromocresol purple and the measurement of albumin. Ann. Clin. Biochem. 20:264-270.
17. IARC Working Group on the Evaluation of Carcinogenic Risk to Humans. 1993. Some naturally occurring substances: food items and constituents. heterocyclic aromatic amines and mycotoxins. International Agency for Research on Cancer, Lyon, France.
18. Kensler, T. W., X. He, M. Otieno, P. Egner, L. Jacobson, B. Chen, J.-S. Wang, Y. Wu, Q.-N. Zhang, G.-S. Qian, S.-Y. Kuang, X. Fang, Y.-F. Li, L.-Y. Yu, H. Prochaska, N. Davidson, G. Gordon, M. Gorman, A. Zarba, C. Enger, A. Munoz, K. Helzlsouer, and J. D. Groopman. 1998. Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkers. Cancer Epidemiol. Biomark. Prev. 7:127-134.
19. Muller, R. 1980. Calculation of average antibody affinity in anti-hapten sera from data obtained by competitive radioimmunoassay. J. Immunol. Methods 34:345-352.
20. Murray, R. W., and R. Jeyaraman. 1985. Dioxiranes: synthesis and reactions of methyldioxiranes. J. Org. Chem. 50:2847-2853.
21. Qian, G.-S., R. K. Ross, M. C. Yu, J.-M. Yuan, Y.-T. Gao, B. E. Henderson, G. N. Wogan, and J. D. Groopman. 1994. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol. Biomark. Prev. 3:3-10.
22. Ross, R. K., J.-M. Yuan, M. C. Yu, G. N. Wogan, G.-S. Qian, J.-T. Tu, J. D. Groopman, Y.-T. Gao, and B. E. Henderson. 1992. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 339:943-946.
23. 1 and their implications for the quantification in biological samples. Chem.-Biol. Interact. 75:1-15.
24. Sabbioni, G., S. Ambs, G. N. Wogan, and J. D. Groopman. 1990. The aflatoxin-lysine adduct quantified by high-performance liquid chromatography from human serum albumin samples. Carcinogenesis 11:2063-2066.
25. Sabbioni, G., P. L. Skipper, G. Buchi, and S. R. Tannenbaum. 1987. Isolation and characterization of the major serum albumin adduct by aflatoxin B1 in vivo in rats. Carcinogenesis 8:819-824.
26. Sheabar, F. Z., J. D. Groopman, G.-S. Qian, and G. N. Wogan. 1993. Quantitative analysis of AF-albumin adducts. Carcinogenesis 14:1203-1208.
27. Skipper, P. L., and S. R. Tannenbaum. 1990. Protein adducts in the molecular dosimetry of chemical carcinogens. Carcinogenesis 11:507-518.
28. Wang, J.-S., and J. D. Groopman. 1999. DNA damage by mycotoxins. Mutat. Res. 424:167-181.
29. Wang, J.-S., T. W. Kensler, and J. D. Groopman. 1998. Toxicants in food: fungal contaminants, p. 29-57. In C. Ioannides (ed.), Nutrition and chemical toxicity. John Wiley & Sons, Inc., New York, N.Y.
30. Wang, J.-S., G.-S. Qian, A. Zarba, X. He, Y.-R. Zhu, B.-C. Zhang, L. Jacobson, S. J. Gange, A. Munoz, T. W. Kensler, and J. D. Groopman. 1996. Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen positive and negative residents of Daxin, Qidong County, People's Republic of China. Cancer Epidemiol. Biomark. Prev. 5:253-261.
31. 1 by oltipraz in residents of Qidong, People's Republic of China. J. Natl. Cancer Inst. 91:347-354.
32. Wild, C. P., G. J. Hudson, G. Sabbioni, B. Chapot, A. J. Hall, G. N. Wogan, H. Whittle, R. Montesano, and J. D. Groopman. 1992. Dietary intake of aflatoxins and the level of albumin-bound aflatoxin in peripheral blood in The Gambia, West Africa. Cancer Epidemiol, Biomark. Prev. 1:229-234.
33. Wild, C. P., Y.-Z. Jiang, G. Sabbioni, B. Chapot, and R. Montesano. 1990. Evaluation of methods for quantitation of aflatoxin-albumin adducts and their application to human exposure assessment. Cancer Res. 50:245-251.
34. Wogan, G. N. 1992. Aflatoxins as risk factors for hepatocellular carcinoma in humans. Cancer Res. 52(Suppl.):2114s-2118s.
35. 1 albumin adduct level and risk of hepatocellular carcinoma. Proc. Am. Assoc. Cancer Res. 36:1644.